发明名称 Nucleic Acids Encoding Antibody Molecules Which Bind IL-17A and IL-17F
摘要 The invention relates to antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
申请公布号 US2015322147(A1) 申请公布日期 2015.11.12
申请号 US201514706234 申请日期 2015.05.07
申请人 UCB Pharma S.A. 发明人 Adams Ralph;Popplewell Andrew George;Rapecki Stephen Edward
分类号 C07K16/24;A61K39/395 主分类号 C07K16/24
代理机构 代理人
主权项 1. A method of treating an IL-17A and/or IL-17F mediated pathological condition in a mammal comprising the step of administering to the mammal a therapeutically effective amount of a pharmaceutical composition comprising a neutralising antibody which binds human IL-17A and human IL-17F, wherein the neutralising antibody cross-blocks the binding of an antibody that binds human IL-17A and human IL-17F and has a heavy chain comprising sequence given in SEQ ID NOs:9 or 15 and a light chain comprising sequence given in SEQ ID NOs:7 or 11 to human IL-17A and/or human IL-17F and/or IL-17A/F heterodimer and/or is cross-blocked from binding human IL-17A and/or human IL-17F and/or IL-17A/F heterodimer by the antibody that binds human IL-17A and human IL-17F and has the heavy chain comprising sequence given in SEQ ID NOs:9 or 15 and the light chain comprising sequence given in SEQ ID NOs:7 or 11, in combination with one or more pharmaceutically acceptable excipients, diluents or carriers.
地址 Brussels BE